- Poster presentation
- Open Access
A conductance-based network model of the basal ganglia for probabilistic action selection
© Shouno et al; licensee BioMed Central Ltd. 2007
- Published: 6 July 2007
- Basal Ganglion
- Selection Probability
- Globus Pallidus
- Projection Neuron
- Action Selection
The basal ganglia (BG) have been implicated in the learning of a sequence of action selections through trial-and-error. A reinforcement learning-based approach has proposed that the cortico-BG circuit is involved in three basic stages of learning: evaluation of actions, probabilistic selection of an action, and learning from experience. The striatum and mid-brain dopaminergic neurons have been suggested as neural substrates for the first and third stages. Theoretical studies have pointed out the importance of a probabilistic action selection mechanism for learning and on-line adaptation of the behavior. However, the neural substrate of the action selection is still an open question. Our hypothesis for the issue is that the indirect pathway of the BG selects an action to be executed and the direct pathway determines the timing of its execution. Using a conductance-based network model of spiking neurons, we show that the dynamics in the network of the globus pallidus external and the subthalamic nucleus in the indirect pathway provides binary modulation on the substantia nigra par reticulata, that signals a selected action. Furthermore, binary modulation occurs stochastically, and the selection probability is sensitive to inhibitory input on the globus pallidus. These results suggests that the subthalamopallidal network is capable of probabilistic action selection and the selection probability can be biased by the activities of the striatopallidal projection neurons in the indirect pathway, hence can be optimally tuned by the strength of the cortico-striatal synapses through dopamine-dependent plasticity. We conclude that the indirect pathway of the BG is a neural substrate of the probabilistic action selection.
This article is published under license to BioMed Central Ltd.